ANIP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ANI Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 71.65 USD 1.39% Market Closed

Market Cap: $1.6B

	ANI Pharmaceuticals Inc NASDAQ:ANIP	US
G	Goldhills Holding Ltd OTC:GODZF	CA
C	Cooper-Standard Holdings Inc F:C31	US
	Implenia AG F:I8T	CH
A	ASM International NV XHAN:AVS	NL
A	Apple Inc BMV:AAPL	US
M	Merck KGaA F:MRK	DE
P	Pax Global Technology Ltd F:P8X	HK
D	Dai-Dan Co Ltd TSE:1980	JP
	NRJ Group SA PAR:NRG	FR
	Banca Mediolanum SpA F:ME1	IT
L	Landstar System Inc SWB:LDS	US

Profitability Summary

ANI Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

63% > 60%

Healthy Operating Margin

15%

Low 3Y Average Operating Margin

Operating Margin is Increasing

10% > 15%

Healthy Net Margin

10%

Low 3Y Average Net Margin

Net Margin is Increasing

2% > 10%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

16%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.